Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iriondo, A.
Right arrow Articles by Zubizarreta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iriondo, A.
Right arrow Articles by Zubizarreta, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Complete recovery of hemopoiesis following bone marrow transplant in a patient with unresponsive congenital hypoplastic anemia (Blackfan- Diamond syndrome)

A Iriondo, J Garijo, J Baro, E Conde, JM Pastor, A Sabanes, V Hermosa, MC Sainz, L Perez de la Lastra and A Zubizarreta

Allogeneic bone marrow transplantation (BMT) was carried out on a 5- year-old boy with congenital hypoplastic anemia (CHA), who did not respond to corticosteroids and who was displaying signs of progressive hemosiderosis. Pretransplant preparation had to be modified because respiratory failure and cerebral edema supervened. This preparatory regimen consisted of busulfan (2 mg/kg for four days), cyclophosphamide (50 mg/kg for one day), and total body irradiation (750 rad). Hemopoiesis was completely restored and is still maintained 650 days after transplantation. This is the second published report on the use of BMT to treat a patient with CHA, and it is the first time it has resulted in long-term survival. BMT should be considered for patients with CHA who do not respond to corticosteroids.

Volume 64, Issue 2, pp. 348-351, 08/01/1984
Copyright © 1984 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
I. Hamaguchi, A. Ooka, A. Brun, J. Richter, N. Dahl, and S. Karlsson
Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia
Blood, September 26, 2002; 100(8): 2724 - 2731.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R Parkman
The application of bone marrow transplantation to the treatment of genetic diseases
Science, June 13, 1986; 232(4756): 1373 - 1378.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1984 by American Society of Hematology         Online ISSN: 1528-0020